Aggarwal, Arpit
Madill, Morgann
Jana, Mayukhmala
Pathak, Tilak
Starr, Timothy K.
Winterhoff, Boris
Tessier, Katelyn M.
Erickson, Britt K.
Nelson, Andrew C.
Lou, Emil
Madabhushi, Anant https://orcid.org/0000-0002-5741-0399
Bazzaro, Martina https://orcid.org/0000-0002-9426-9515
Funding for this research was provided by:
University of Minnesota Grand Challenges Initiative
Ovarian Cancer Research Alliance
Adelson Medical Research Foundation
Research Scholar Grant (RSG-22-022-01-CDP)
Research Scholar Grant (RSG-22-022-01-CDP)
Biostatistics Core - NIH (P30 CA77598)
National Center for Advancing Translational Sciences of the National Institutes of Health (Award Number 7)
University of Minnesota Clinical Center for the Study of Pancreatic Disease, part of The Chronic Pancreatitis Diabetes Pancreatic Cancer research (CPDPC) consortium (5U01DK126300-03)
National Cancer Institute (R01CA249992-01A1, R01CA202752-01A1, R01CA208236-01A1, R01CA216579-01A1, R01CA220581-01A1, R01CA257612-01A1, 1U01CA239055-01, 1U01CA248226-01, 1U54CA254566-01)
National Cancer Institute (R01CA249992-01A1, R01CA202752-01A1, R01CA208236-01A1, R01CA216579-01A1, R01CA220581-01A1, R01CA257612-01A1, 1U01CA239055-01, 1U01CA248226-01, 1U54CA254566-01)
National Heart, Lung, and Blood Institute (1R01HL15127701A1, R01HL15807101A1)
National Institute of Biomedical Imaging and Bioengineering (1R43EB028736-01)
National Center for Research Resources (1 C06 RR12463-01)
VA Merit Review Award (IBX004121A)
Office of the Assistant Secretary of Defense for Health Affairs (W81XWH-19-1-0668, W81XWH-15-1-0558, W81XWH-20-1-0851, W81XWH-18-1-0440, W81XWH-20-1-0595)
Mayo Clinic Breast Cancer SPORE grant (P50 CA116201)
Kidney Precision Medicine Project (KPMP) Glue Grant
Article History
Received: 26 August 2025
Revised: 11 December 2025
Accepted: 12 January 2026
First Online: 6 February 2026
Competing interests
: AM is an equity holder in Elucid Bioimaging, Picture Health and in Inspirata Inc. In addition, he serves on the advisory board of Picture Health Inc. He also has sponsored research agreements with AstraZeneca and Bristol Myers Squibb. His technology has been licensed to Elucid Bioimaging and to Picture Health. He is also involved in a R01 grant with Inspirata Inc. Dr. Lou discloses financial interest in Ryght, Inc., a privately held company. Dr. Erickson serves on advisory boards for AstraZeneca, Merck, GSK, Gilead, and Abbvie.
: This study was approved by the Institutional Review Board of the University of Minnesota (No. 1312M46201 and 1611M99903), and performed in accordance with the Declaration of Helsinki. Informed consent was obtained from each participant.